The Vanguard Group Discloses Position in Mural Oncology plc

The Vanguard Group, Inc. has disclosed its interests and positions in Mural Oncology plc, as required under Rule 8.3 of the Irish Takeover Panel Act. The form, dated October 3, 2025, reveals that Vanguard holds 288,539 ordinary shares of Mural Oncology, representing a 1.67% interest in the company's securities.

No dealings in cash-settled or stock-settled derivatives are reported, maintaining Vanguard's disclosed position solely in ordinary shares. Over the reporting period, Vanguard purchased an additional 80 shares at a price of 2.08 USD per share.

No additional agreements, inducements, or derivative positions were noted, simplifying Vanguard's position to direct equity ownership. The company confirmed the absence of related indemnity or option arrangements.